Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 277.53M
March 31, 2026 167.01M
December 31, 2025 229.67M
September 30, 2025 408.90M
June 30, 2025 161.86M
March 31, 2025 268.24M
December 31, 2024 310.23M
September 30, 2024 415.07M
June 30, 2024 216.43M
March 31, 2024 327.08M
December 31, 2023 429.17M
September 30, 2023 343.64M
June 30, 2023 206.60M
March 31, 2023 175.50M
December 31, 2022 -40.02M
September 30, 2022 188.29M
June 30, 2022 171.56M
March 31, 2022 226.92M
December 31, 2021 271.70M
September 30, 2021 260.32M
June 30, 2021 128.55M
March 31, 2021 111.92M
December 31, 2020 204.37M
September 30, 2020 127.46M
June 30, 2020 117.84M
Date Value
March 31, 2020 142.76M
December 31, 2019 133.17M
September 30, 2019 158.15M
June 30, 2019 22.13M
March 31, 2019 94.63M
December 31, 2018 56.36M
September 30, 2018 125.03M
June 30, 2018 38.00M
March 31, 2018 39.64M
December 31, 2017 105.58M
September 30, 2017 123.05M
June 30, 2017 11.90M
March 31, 2017 159.33M
December 31, 2016 123.47M
September 30, 2016 51.83M
June 30, 2016 17.89M
March 31, 2016 59.32M
December 31, 2015 112.47M
September 30, 2015 74.24M
June 30, 2015 28.08M
March 31, 2015 61.11M
December 31, 2014 65.31M
September 30, 2014 110.99M
June 30, 2014 -54.92M
March 31, 2014 38.66M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 558.00M
Medpace Holdings, Inc. 162.01M
Proteome Sciences Plc --
Champions Oncology, Inc. -1.998M
Avantor, Inc. 178.20M